Skip to main content
. 2024 Mar 8;16(6):1093. doi: 10.3390/cancers16061093

Figure 1.

Figure 1

Illustration of a case of multiple brain metastases from lung cancer without drivers’ mutation treated in August 2018. In February 2021, he developed 16 BM. He had four sessions of SRS (20 Gray to the 70% isodose line): PTV_01 in February 2021 (n = 16); PTV_02 in May 2021 (n = 3); PTV_03 in August 2021 (n = 2); and PTV_04 in October 2021 (n = 3). He had no new brain metastases until the last MRI in April 2022. (A): three-dimensional image of the brain and the target BM: red: PTV_01; orange: PTV_02; pink: PTV_03; green: PTV_04. (B): axial CT-scan slice, showing the patient’s dose-color-wash, (C): Dose-Volume Histogram.